In several prostate adenocarcinomas, this ab33029 HIC1 antibody failed to detect any significant HIC1 expression in cancer cells but again a predominant expression in the stromal compartment (Figure 2C). This evidence concerns the gene HIC1 and prostate adenocarcinoma.